Colorectal Cancer Rates Significantly Rising among Younger Adults and Teens, According to New Research
DDW 24. Among patients aged 15 to 19 years, the incidence of CRC rose 333% over a 22-year period, researchers reported.
Teal Health Granted Breakthrough Device Designation for Self-Collect Cervical Cancer Screening Device
FDA Approves Novel Noninvasive Multitarget Stool RNA CRC Screening Test: Daily Dose
Your daily dose of the clinical news you may have missed.
Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
Use of Most Contraceptive Methods Decreased from 2019-2022: Daily Dose
Hip Pain in a Man with Type 1 Diabetes: Seen in the ED
Patient is in his forties; pain has been waxing, waning, worsening for 2 weeks. He has no other significant medical history. Do lab results hold clues? What's your Dx?
Pilot Referral Program May Help Increase Postpartum Visits to Primary Care Clinicians
Women referred from obstetrics to primary care postpartum via a pilot program were more likely to attend a PCP visit than nonreferred women.
FDA Reports More than 200 Injuries Related to Recalled Tandem Diabetes Insulin App
There have been 224 reported injuries as of April 15, 2024, the CDC said, but no reports of death related to the app intermittently crashing and rebooting.
Budesonide-Based Triple Therapy Most Cost-Effective vs Dual Therapy for COPD
A new analysis found triple therapy for COPD, particularly B/G/F, more cost-effective vs dual therapy in terms of exacerbations and quality-adjusted life years.
AstraZeneca at ATS 2024: Look for Late-Breaking Data on Novel Therapeutics for COPD
The company will present new data on effects of tezepelumab in COPD and of inhaled triple therapy Breztri on cardiopulmonary outcomes in COPD.
Poor Cardiovascular-Kidney-Metabolic Health “Widespread” among US Adults, According to New Study
Results also showed that older adults, men, and Black adults face an increased risk of advanced stages of CKM syndrome.
Anxiety Raises Risk for Acute Exacerbations in Older Adults with COPD: Daily Dose
Donanemab FDA AdComm Hearing Scheduled for June 10, Eli Lilly Says
The AdComm plans to review data from the TRAILBLAZER-ALZ 2 phase 3 clinical trial that served as the foundation for Eli Lilly's original BLA submission to the FDA.
FDA Approves ColoSense, Novel Noninvasive Multitarget Stool RNA CRC Screening Test
In average-risk individuals, the at-home ColoSense test demonstrated 93% sensitivity for detecting CRC and 45% sensitivity for detecting advanced adenomas.
Severe Maternal Morbidity Associated with Mental Health Risks Post-Delivery: Daily Dose
Preconception Vaping, Alcohol Use Had “No Meaningful Association” with Spontaneous Abortion in New Study
AUA 2024. Neither use of alcohol nor vaping/cigarette smoking by either parent during preconception was "appreciably" linked to an incident event, new research found.
SGLT2 Inhibitor Use Improves Quality of Life, Functional Capacity in Patients with Heart Failure
Patients with HF who received SGLT2i therapy had significant improvement in functional capacity and QOL, regardless of sex, diabetes status, or ejection fraction, report researchers.
CV Risk Prevention Profiles Significantly Worse Following Stroke vs MI in 2 Large National Cohorts
Study participants who had a history of stroke were nearly 60% less likely to meet guideline-recommended secondary prevention goals, new research reveals.
Adults with Prior Antiobesity Medication Use Before Semaglutide Use Lose More Weight: Daily Dose
sNDA for Brexpiprazole/Sertraline Combination for PTSD Submitted for FDA Review
The sNDA for the brexpiprazole plus sertraline therapy is based on positive phase 2 and 3 clinical trials showing improvement in PTSD-specific scale scores.
